AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Restart Life Sciences Corp.
Video analysis: NMLSF
All videosNo video analysis for this stock yet. Request one from our team.
News: NMLSF
Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce its financial and operating results for the three and six months ended June 30, 2026. All financial figures are expressed in Canadian dollars ($) unless otherwise noted, are prepared in accordance with International Financial Reporting Standards (IFRS), and are unaudited.
Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its premium functional food brand, Holy Crap Foods Inc. ("Holy Crap"), has officially launched in the U.S. market through the Amazon USA platform. The initial U.S. rollout features two of the brand's top-performing super seed SKUs alongside a popular variety package.
Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), has officially commenced commercial production of its highly anticipated new protein-focused product line. This marks a significant milestone in the Company's product development roadmap and underscores its core focus on revenue generation, scalable innovation, and expanding its "better-for-you" functional food portfolio.
Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a corporate update on its strategic growth initiatives as the Company actively pursues targeted merger and acquisition opportunities to further expand its presence in the health and wellness segments of the consumer packaged goods sector. Following the acquisition and successful operational rollout of wholly owned subsidiary Holy Crap Foods Inc. ("Holy Crap"), Restart Life is positioning itself as an active acquirer.
Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is providing a corporate update regarding its upcoming expansion into the United States, the launch of an updated AI-driven e-commerce platform, and pipeline developments for its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"). The Company remains focused on scaling operations, driving revenue generation, and expanding its distribution reach.
Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a strategic operational update regarding its collaboration with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. Following the recent unveiling of its newly formulated product roadmap, targeted to capitalize on emerging consumer shopping patterns, the Company has successfully integrated the results from its collaboration with the RCFTR into its upcoming formulations.
Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its forward-looking product development and segment expansion roadmap for its wholly owned subsidiary, Holy Crap Foods Inc. Following the Company's recent disclosure of its preliminary June 2026 financial growth highlights, management is working to build upon this operational trajectory by systematically diversifying the Holy Crap brand into specialized consumer demographics. Following the successful completion of its market research and conceptual design phases, the Company has advanced into formulation testing for a new product line targeting the premium youth breakfast sector.
Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to report its preliminary, unaudited financial results for the month of June 2026 regarding its wholly owned subsidiary, Holy Crap Foods Inc., alongside an update on internal operational infrastructure and market expansion initiatives. Following the acquisition of Holy Crap Foods Inc. on February 27, 2026, the Company has focused on integrating operations, improving channel efficiencies, and expanding distribution networks.
